HK Stock MarketDetailed Quotes

ZHAOKE OPHTH-B (06622)

Watchlist
  • 2.660
  • -0.070-2.56%
Market Closed May 15 16:05 CST
1.46BMarket Cap-6.30P/E (TTM)

ZHAOKE OPHTH-B (06622) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
销售眼科药物27.43M85.78%
Sale of other drugs1.6M5.00%
销售眼科产品1.51M4.72%
独家分销权收入1.28M3.99%
CMO服务收入162K0.51%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
销售眼科药物27.43M85.78%
Sale of other drugs1.6M5.00%
销售眼科产品1.51M4.72%
独家分销权收入1.28M3.99%
CMO服务收入162K0.51%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
China Mainland29.85M93.35%
South Korea1.09M3.40%
中国香港(所在地)614K1.92%
Other424K1.33%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More